Stockreport

Syros’ Drug Discovery Research in Immuno-Oncology Highlighted in Oral Presentation at American College of Surgeons Clinical Congress

Syros Pharmaceuticals, Inc.  (SYRS) 
Last syros pharmaceuticals, inc. earnings: 3/5 06:57 am Check Earnings Report
US:NASDAQ Investor Relations: ir.syros.com
PDF Analysis of Regulatory Genomes of Cells Isolated from Pancreatic Cancer Patient Tumors Leads to Identification of New Drug Targets Findings Under [Read more]